Review of 1027 patients with newly diagnosed multiple myeloma.
Explore this paper's citation graph
Summary
Multivariate analysis revealed that age, plasma cell labeling index, low platelet count, serum albumin value, and the log of the creatinine value were the most important prognostic factors for newly diagnosed multiple myeloma.
- Type
- article
- Published
- 2003-01-01
- Cited by
- 2,416
- References
- 48
- OpenAlex
- https://openalex.org/W2160088903
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23373117
Keywords
Medicine, Multiple myeloma, Serum protein electrophoresis, Creatinine, Immunofixation
References
- Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.
- Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.
- Magnetic resonance imaging of the bone marrow in hematologic malignancies.
- Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
- A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM).
- Total therapy with tandem transplants for newly diagnosed multiple myeloma.
- Multiple myeloma: review of 869 cases.
- Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.
- Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
- Multiple myeloma in young patients: clinical presentation and treatment approach.
- Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
- Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
- Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.
- High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.
- Fever of unknown origin caused by multiple myeloma: a report of 9 cases.
- Computed tomography in diagnosis and management of multiple myeloma and its variants.
- Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)
- Aggressive plasma cell myeloma. A terminal phase.
- Hematopoiesis and cytokines. Relevance to cancer and aging.
- Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.
Cited by
- Molecular profiling in multiple myeloma
- Cost effectiveness of bortezomib in the treatment of advanced multiple myeloma.
- Pain reduction after percutaneous vertebroplasty for myeloma-associated vertebral fractures.
- Toward Personalized Medicine: The potential role of RNA interference in Plasma Cell Dyscrasia
- The biology of immunoglobulin free light chains in kidney disease: a study of Monoclonal and Polyclonal light chains
- Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
- Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells.
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- Multiple myeloma: Vague symptoms can challenge diagnostic skills
- Supportive therapy in multiple myeloma.
- Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy
- A Case of Multiple Myeloma Coexisting with Primary Hyperparathyroidism and Review of the Literature
- The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: Final results on 205 patients of the Greek myeloma study group
- Dimethyl sulphoxide does not contribute to renal failure in patients undergoing stem cell transplant for multiple myeloma and primary amyloidosis.
- Value of reflex testing based on hypogammaglobulinemia as demonstrated in serum protein electrophoresis.
- Renale Manifestationen von Leichtkettenerkrankungen – Epidemiologie und Prognose
- Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy
- Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma
- An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma
- Hypoglossal Nerve Mononeuropathy as the First Presenting Symptom of Progressing Multiple Myeloma
Related papers
- [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
- Utility of urine electrophoresis for paraprotein detection: a comparison with serum electrophoresis/immunofixation and free light chain measurement
- Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
- κ and λ urine free light chains: a new method for quantification
- Explore prognostic significance of the diagnostic method for multiple myeloma
- Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Underproduction and Underdetection of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
- Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
- Evaluation of monoclonal gammopathies in the "well" elderly.
- Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and kappa/lambda quantification.
- A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female